Early On® Michigan Established Conditions
List of Established Conditions that indicate automatic eligibility for Early On® supports and services. Conditions must be diagnosed by an appropriate health care or mental health provider and include, but are not limited to, the following:
1. Congenital Anomalies 1.9. Other and Unspecified 4.3. Abnormalities of Amino Acid 1.1. Central Nervous System Bardet-Beidl Syndrome Metabolism Agenesis of the Corpus Callosum Fragile X Syndrome Argininosuccinic Aciduria Holoprosencephaly Citrullinemia 2. Chromosomal Anomalies Homocystinuria Hydrocephalus w/o Spina Bifida Angelman Syndrome Infant Phenylketonuria (PKU) Microcephalus Cri-du-Chat Maple Syrup Urine Disease Spina Bifida w/o Anencephaly DiGeorge Syndrome Methylmalonic Acidemia (MMA) 1.2. Eye, Ear, Face and Neck (Velo-Cardial-Facial Syndrome) Ornithine Transcarbamylase Deficiency Anopthalmos/Micropthalmos Kleinfelter Syndrome Anotia/Microtia Prader—Willi Syndrome 4.4. Abnormalities of Carbohydrate Metabolism CHARGE Syndrome Trisomy 21 (Down Syndrome) Galactosemia Congenital Cataract Trisomy 13 (Patau Syndrome) Glycogen Storage Disease Pierre Robin Sequence Trisomy 18 (Edwards Syndrome) Treacher Collins Turner Syndrome 4.5. Abnormalities of Lipid Metabolism Gaucher Disease 1.3. Heart and Circulatory System Williams Syndrome Niemann Pick Disease Aortic Valve Atresia & Stenosis 3. Infectious Conditions Coarctation of Aorta 4.6. Abnormalities of the Purine/Pyrimidine 3.1. Congenital Infections Metabolism Hypoplastic Left Heart HIV / AIDS Lesch Nyhan Syndrome Patent Ductus Arteriosus (PDA) Syphilis Tetralogy of Fallot 4.7. Abnormalities of the Parathyroid TORCH: Untreated Hyperparathyroidism 1.4. Respiratory System Toxoplasmosis Untreated Hypoparathyroidism Choanal Atresia Rubella 4.8. Abnormalities of the Pituitary Lung Agenesis/Hypoplasia Cytomegalovirus Hyperpituitary 1.5. Cleft Lip & Palate Herpes Hypopituitary Cleft Palate w/o Cleft Lip 3.2. Acquired Infections Cleft Lip w/ and w/o Cleft Palate 4.9. Abnormalities of Adrenocortical Bacterial Meningitis Function 1.6. Digestive System Encephalitis Congenital Adrenal Hyperplasia Esophageal Atresia/Tracheoesophageal Poliomyelitis Hyperadrenocortical Function Fistula Viral Meningitis Hypoadrenocortical Function Hirschsprung’s Disease Pyloric Stenosis 4. Endocrine/Metabolic Disorders 4.10. Hemoglobinopathies Sickle Cell Disease 1.7. Genital & Urinary Organs 4.1. Mucopolysaccharidosis Thalassemia (major and minor) Hypospadias and Epispadias Hunter Syndrome Renal Agenesis Maroteaux-Lamy Syndrome 4.11. Abnormalities of the Thyroid Sanfilippo Syndrome Hormone 1.8. Musculoskeletal System Scheie Syndrome Congenital Hypothyroidism Achondroplasia Sly Syndrome 4.12. Peroxisomal Disorders Arthrogryposis Adrenoleukodystrophy (ADL) Congenital Hip Dislocation 4.2. Enzyme Deficiency Cerebrohepatorenal Syndrome Lower Limb Reduction Deformities Biotinidase Deficiency (Zellweger Syndrome) Upper Limb Reduction Deformities Medium Chain Acyl-CoA Rhizomelic Chondrodysplasia Punctata Other Congenital Anomalies of the Dehydrogenase Deficiency (MCADD) Musculoskeletal system Oculocerebrorenal Syndrome (Lowe Syndrome)
Note: The Endocrine/Metabolic Disorders Category also includes all disorders tested for in the Michigan Newborn Screening Pro- www.1800EarlyOn.org TK January 2016 Early On® Michigan Established Conditions
List of Established Conditions that indicate automatic eligibility for Early On® supports and services. Conditions must be diagnosed by an appropriate health care or mental health provider and include, but are not limited to, the following:
5. Other Disorders/Diseases 5.2. Vision Impairment 9.2. Medical Illness Amblyopia 5.1. Neurological Disorders Bronchopulmonary Dysplasia Cortical Visual Impairment (CVI) Neuromotor/Muscle Disorders Cancer Low Vision (20/700) Cerebral Palsy Chronic Hepatitis Congenital Myasthenia Nystagmus Connective Tissue Disorders Kernicterus Retinopathy of Prematurity (ROP) Cystic Fibrosis (Stage 3 - Stage 5) Muscular Dystrophies Diabetes Paralysis Visual Field Loss Immune Disorders Periventricular Leukomalacia 6. Hearing Deficiency (ex. Juvenile Arthritis) Torticollis Auditory Neuropathy Organic Failure to Thrive Werdnig Hoffman Disease Bilateral or Unilateral hearing loss of Renal Failure Cerebrovascular Disease ≥ 25 dB at 2+ frequencies between Very Low Birth Weight 500-4000 Hz. Cerebral Arterial Thrombosis (<1500 grams or 3.3 lbs.) Mixed Hearing Loss Cerebral Embolus Thrombosis Chronic Asthma – moderate to severe Cerebral Venous Thrombosis Permanent Conductive Hearing Loss Intrauterine Growth Retardation (IUGR) Brain Hemorrhages Sensorineural Hearing Loss Small for Gestational Age Intracranial Hemorrhage Waardenburg Syndrome (<10% weight for age) (SGA) Intraventricular Hemorrhage 7. Other Fetal/Placental Anomalies (grades III & IV) 10. Developmental Delay Twin to Twin Transfusion Syndrome Degenerative Disorders 10.1. Pervasive Developmental Disorders Umbilical Cord Prolapse Acute Disseminated Autism Spectrum Disorder Encephalomyelitis 8. Exposures Affecting Fetus/Child Childhood Disintegrative Disorder Cockayne Syndrome Pervasive Developmental Disorders Friedreich’s Ataxia 8.1. Prenatal (NOS) Gangliosidosis Fetal Alcohol Spectrum Disorders - 10.2. Rett’s Disorder Kugelberg-Welander Syndrome Diagnosed Leigh’s Disease Fetal Drug Exposure - Diagnosed 10.3. Regulatory Disorders of Sensory Leukodystrophy Maternal PKU Processing Schilder’s Disease Hyposensitive / Hypersensitive 8.2. Postnatal Tay Sachs Disease Sensory-Seeking/Impulsive Lead – Venous Blood Lead level at or Neurocutaneous Disorders above reference value recommended Block-Sulzberger Syndrome by the CDC (currently 5 µg/dL, Jan. 11. Mental Health Conditions Neurofibromatosis 2016) Adjustment Disorders Sturge Weber Syndrome Mercury – for recent exposure, blood Depression of Infancy and Tuberous Sclerosis level of more than 2 micrograms per Early Childhood Xeroderma Pigmentosa deciliter (>2 µg/dL); for chronic Maltreatment/Deprivation Disorder exposure, urine level of more than (A diagnosis of Reactive Attachment Malignancies 5 micrograms per deciliter (> 5 µg/dL) Disorder should be cross-walked to this Intracranial Tumors and diagnosis which is listed in the DC:0-3R) Other Malignancies of the CNS 9. Chronic Illness Disorders of Affect Head and Spinal Cord Trauma 9.1. Medically Fragile Mixed Disorders of Emotional Fracture of vertebral column with or Expressiveness Renal Insufficiency without spinal cord lesions Post Traumatic Stress Disorder (PTSD) Shaken Baby Syndrome Regulatory Disorders** Traumatic Brain Injury Hypoxic/Anoxic Brain Injury ** Difficulties in regulating physiological, Hypoxic Ischemic Encephalopathy attentional, motor or affective processes, and in organizing a calm, alert or affectively positive (Newborn Encephalopathy) state. These disorders affect the child’s daily Near Drowning routines and interpersonal relationships. Must be diagnosed by a qualified professional. (Greenspan, 1992)
Note: The Endocrine/Metabolic Disorders Category also includes all disorders tested for in the Michigan Newborn Screening Pro- www.1800EarlyOn.org TK January 2016